Skip to content
Health Portal
Answers, One Place
  • Condition Guides
  • Lab Explainers
  • Specialist Directory
  • Symptom Checker
  • Treatment Timelines
Akeso, Summit’s Ivonescimab Shows Survival Benefit in NSCLC

Akeso, Summit’s Ivonescimab Shows Survival Benefit in NSCLC

by Beatrice Gray • 4 hours ago
Arlo points to promising Phase II data for swelling disorder drug

Arlo points to promising Phase II data for swelling disorder drug

by Nabila Anuar • 1 day ago
Arlo points to promising Phase II data for swelling disorder drug

Arlo points to promising Phase II data for swelling disorder drug

by Nabila Anuar • 1 day ago
Arlo points to promising Phase II data for swelling disorder drug

Arlo points to promising Phase II data for swelling disorder drug

by Nabila Anuar • 1 day ago

Symptom Checker

Jazz reports interim Phase III results for Ziihera

Jazz reports interim Phase III results for Ziihera

by Nabila Anuar • 5 days ago

Condition Guides

Sensorion Wins Approval for HearConnex Trial in France
Condition Guides

Sensorion Wins Approval for HearConnex Trial in France

by Rina Raha • 2 days ago
Sensorion Wins Approval for HearConnex Trial in France
Condition Guides

Sensorion Wins Approval for HearConnex Trial in France

by Rina Raha • 2 days ago
Sensorion Wins Approval for HearConnex Trial in France
Condition Guides

Sensorion Wins Approval for HearConnex Trial in France

by Rina Raha • 2 days ago
Morden Park’s Dazzling Displays: Showcasing London’s Finest Rings
Condition Guides

Morden Park’s Dazzling Displays: Showcasing London’s Finest Rings

by Rina Raha • 6 days ago

MOST READ

  • Akeso, Summit’s Ivonescimab Shows Survival Benefit in NSCLC
    Akeso, Summit’s Ivonescimab Shows Survival Benefit in NSCLC
  • HiRO partners with Differentia Biotech for trial simulation
    HiRO partners with Differentia Biotech for trial simulation
  • Jazz reports interim Phase III results for Ziihera
    Jazz reports interim Phase III results for Ziihera
  • First patient receives BHB810 in BigHat study
    First patient receives BHB810 in BigHat study
  • Ocugen starts trial of new eye treatment
    Ocugen starts trial of new eye treatment
  • Sensorion Wins Approval for HearConnex Trial in France
    Sensorion Wins Approval for HearConnex Trial in France

LATEST NEWS

Akeso, Summit’s Ivonescimab Shows Survival Benefit in NSCLC
Specialist Directory
Akeso, Summit’s Ivonescimab Shows Survival Benefit in NSCLC
4 hours ago
Arlo points to promising Phase II data for swelling disorder drug
Symptom Checker
Arlo points to promising Phase II data for swelling disorder drug
1 day ago
Arlo points to promising Phase II data for swelling disorder drug
Symptom Checker
Arlo points to promising Phase II data for swelling disorder drug
1 day ago
Arlo points to promising Phase II data for swelling disorder drug
Symptom Checker
Arlo points to promising Phase II data for swelling disorder drug
1 day ago
Arlo points to promising Phase II data for swelling disorder drug
Symptom Checker
Arlo points to promising Phase II data for swelling disorder drug
1 day ago
Sensorion Wins Approval for HearConnex Trial in France
Condition Guides
Sensorion Wins Approval for HearConnex Trial in France
2 days ago
Sensorion Wins Approval for HearConnex Trial in France
Condition Guides
Sensorion Wins Approval for HearConnex Trial in France
2 days ago
Sensorion Wins Approval for HearConnex Trial in France
Condition Guides
Sensorion Wins Approval for HearConnex Trial in France
2 days ago
Arlo points to promising Phase II data for swelling disorder drug
Symptom Checker
Arlo points to promising Phase II data for swelling disorder drug
Nabila Anuar • 1 day ago
Arlo points to promising Phase II data for swelling disorder drug
Arlo points to promising Phase II data for swelling disorder drug
1 day ago
Arlo points to promising Phase II data for swelling disorder drug
Arlo points to promising Phase II data for swelling disorder drug
1 day ago
Arlo points to promising Phase II data for swelling disorder drug
Arlo points to promising Phase II data for swelling disorder drug
1 day ago
Sensorion Wins Approval for HearConnex Trial in France
Condition Guides
Sensorion Wins Approval for HearConnex Trial in France
Rina Raha • 2 days ago
Sensorion Wins Approval for HearConnex Trial in France
Sensorion Wins Approval for HearConnex Trial in France
2 days ago
Sensorion Wins Approval for HearConnex Trial in France
Sensorion Wins Approval for HearConnex Trial in France
2 days ago
Morden Park’s Dazzling Displays: Showcasing London’s Finest Rings
Morden Park’s Dazzling Displays: Showcasing London’s Finest Rings
6 days ago
Akeso, Summit’s Ivonescimab Shows Survival Benefit in NSCLC
Specialist Directory
Akeso, Summit’s Ivonescimab Shows Survival Benefit in NSCLC
Beatrice Gray • 4 hours ago
First patient receives BHB810 in BigHat study
First patient receives BHB810 in BigHat study
4 days ago
Ocugen starts trial of new eye treatment
Lab Explainers
Ocugen starts trial of new eye treatment
Nabila Anuar • 3 days ago
HiRO partners with Differentia Biotech for trial simulation
HiRO partners with Differentia Biotech for trial simulation
6 days ago

Specialist Directory

Akeso, Summit’s Ivonescimab Shows Survival Benefit in NSCLC

Akeso, Summit’s Ivonescimab Shows Survival Benefit in NSCLC

by Beatrice Gray • 4 hours ago
First patient receives BHB810 in BigHat study

First patient receives BHB810 in BigHat study

by Nabila Anuar • 4 days ago

Lab Explainers

Lab Explainers

Ocugen starts trial of new eye treatment

by Nabila Anuar • 3 days ago
Ocugen starts trial of new eye treatment
HiRO partners with Differentia Biotech for trial simulation
by Beatrice Gray • 6 days ago
HiRO partners with Differentia Biotech for trial simulation

BETTER LIVING

Arlo points to promising Phase II data for swelling disorder drug

Arlo points to promising Phase II data for swelling disorder drug

By Nabila Anuar • 1 day ago
Arlo points to promising Phase II data for swelling disorder drug

Arlo points to promising Phase II data for swelling disorder drug

By Nabila Anuar • 1 day ago
Sensorion Wins Approval for HearConnex Trial in France

Sensorion Wins Approval for HearConnex Trial in France

By Rina Raha • 2 days ago

ALL POST

Akeso, Summit’s Ivonescimab Shows Survival Benefit in NSCLC
Specialist Directory

Akeso, Summit’s Ivonescimab Shows Survival Benefit in NSCLC

by Beatrice Gray • 4 hours ago
Arlo points to promising Phase II data for swelling disorder drug
Symptom Checker

Arlo points to promising Phase II data for swelling disorder drug

by Nabila Anuar • 1 day ago
Arlo points to promising Phase II data for swelling disorder drug
Symptom Checker

Arlo points to promising Phase II data for swelling disorder drug

by Nabila Anuar • 1 day ago
Arlo points to promising Phase II data for swelling disorder drug
Symptom Checker

Arlo points to promising Phase II data for swelling disorder drug

by Nabila Anuar • 1 day ago
Arlo points to promising Phase II data for swelling disorder drug
Symptom Checker

Arlo points to promising Phase II data for swelling disorder drug

by Nabila Anuar • 1 day ago
Sensorion Wins Approval for HearConnex Trial in France
Condition Guides

Sensorion Wins Approval for HearConnex Trial in France

by Rina Raha • 2 days ago
Sensorion Wins Approval for HearConnex Trial in France
Condition Guides

Sensorion Wins Approval for HearConnex Trial in France

by Rina Raha • 2 days ago
Sensorion Wins Approval for HearConnex Trial in France
Condition Guides

Sensorion Wins Approval for HearConnex Trial in France

by Rina Raha • 2 days ago
Ocugen starts trial of new eye treatment
Lab Explainers

Ocugen starts trial of new eye treatment

by Nabila Anuar • 3 days ago
First patient receives BHB810 in BigHat study
Specialist Directory

First patient receives BHB810 in BigHat study

by Nabila Anuar • 4 days ago
1 2 Next page

Latest Post

  • Akeso, Summit’s Ivonescimab Shows Survival Benefit in NSCLC
  • Arlo points to promising Phase II data for swelling disorder drug
  • Arlo points to promising Phase II data for swelling disorder drug
  • Arlo points to promising Phase II data for swelling disorder drug
  • Arlo points to promising Phase II data for swelling disorder drug
  • Sensorion Wins Approval for HearConnex Trial in France
  • Sensorion Wins Approval for HearConnex Trial in France

About

  • About Us
  • Contact Us
  • Disclosure Policy
  • Sitemap
  • Terms of Service

Social Media

Facebook Facebook
YouTube YouTube
Twitter Twitter / X
Instagram Instagram
Health Portal

Answers, One Place

Categories

  • Symptom Checker
  • Condition Guides
  • Specialist Directory
  • Lab Explainers
  • Treatment Timelines

About

  • About Us
  • Contact Us
  • Disclosure Policy
  • Terms of Service
  • Sitemap

Latest Post

  • Akeso, Summit’s Ivonescimab Shows Survival Benefit in NSCLC
  • Arlo points to promising Phase II data for swelling disorder drug
  • Arlo points to promising Phase II data for swelling disorder drug
  • Arlo points to promising Phase II data for swelling disorder drug
  • Arlo points to promising Phase II data for swelling disorder drug
© 2026 Health Portal. All Rights Reserved.